Skip to main content
. 2021 May 2;14(4):1423–1430. doi: 10.1111/cts.12991

Figure 1.

Figure 1

Concentration‐time curve for plasma durlobactam after a 4 g dose, n = 31 (pharmacokinetic [PK] population)